0.6750
+0.0300
+(4.65%)
As of 8:03:02 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-17,730.0000
-9,484.0000
-7,691.0000
-25,241.0000
Investing Cash Flow
--
-9,742.0000
1,699.0000
19,872.0000
-2,694.0000
Financing Cash Flow
--
21,810.0000
15.0000
837.0000
26,457.0000
End Cash Position
--
7,863.0000
13,598.0000
21,235.0000
8,272.0000
Income Tax Paid Supplemental Data
--
--
--
34.0000
7.0000
Capital Expenditure
--
-134.0000
-171.0000
-143.0000
-449.0000
Issuance of Capital Stock
--
21,542.0000
--
505.0000
26,306.0000
Free Cash Flow
--
-17,864.0000
-9,655.0000
-7,834.0000
-25,690.0000
12/31/2020 - 7/16/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GYRE Gyre Therapeutics, Inc.
11.27
-1.87%
ARTV Artiva Biotherapeutics, Inc.
5.33
-0.93%
PEPG PepGen Inc.
1.5450
-16.03%
XBIT XBiotech Inc.
3.6000
-0.28%
LSB LakeShore Biopharma Co., Ltd
2.8800
+13.39%
PASG Passage Bio, Inc.
0.5747
-0.29%
INAB IN8bio, Inc.
0.2609
-2.58%
ALEC Alector, Inc.
1.6950
+3.34%
ENZC Enzolytics, Inc.
0.0009
0.00%
SNDX Syndax Pharmaceuticals, Inc.
14.34
+0.67%